Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...
Amid steep cuts to US foreign assistance, the Trump administration is touting a new plan to provide a powerful HIV-prevention ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today ...
Merck said on Wednesday that its experimental oral HIV treatment met the main goal of a late-stage trial. The company said ...
Burlington Free Press on MSN
UVM joins major study on drug use and treatment barriers across New England
The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
To put this spike into perspective, the rural city of around 32,000 people has now recorded more HIV cases in two years than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback